| 1 | without | 54,967 |
| 2 | with/without | 244 |
| 3 | /or | 20 |
| 4 | with-out | 4 |
| 5 | adulthood-onset | 3 |
| 6 | nonlateralizing | 3 |
| 7 | pennyroyal | 3 |
| 8 | questionnaire-male | 3 |
| 9 | 2,940-nm | 2 |
| 10 | isourolithin | 2 |
| 11 | non-beta-lactamase | 2 |
| 12 | pre/ | 2 |
| 13 | tj-43-treated | 2 |
| 14 | 'rop | 1 |
| 15 | 1-5x | 1 |
| 16 | 21,694 | 1 |
| 17 | 3-hydroxy-3methylglutaryl-coenzyme | 1 |
| 18 | 4,6-o-benzylidene | 1 |
| 19 | 4.0-706.1 | 1 |
| 20 | 7-without | 1 |
| 21 | c-p. | 1 |
| 22 | canadienne | 1 |
| 23 | con+insoluble | 1 |
| 24 | con+soluble | 1 |
| 25 | cr-without | 1 |
| 26 | curaderos | 1 |
| 27 | cxcl10-treated | 1 |
| 28 | dregs | 1 |
| 29 | early-by | 1 |
| 30 | europe.in | 1 |
| 31 | exposures.in | 1 |
| 32 | fasting.in | 1 |
| 33 | fviia/fx-induced | 1 |
| 34 | had≥two | 1 |
| 35 | lys/kg | 1 |
| 36 | metal-on-polymer | 1 |
| 37 | methotrexate+cyclosporin | 1 |
| 38 | methotrexate+cyclosporine | 1 |
| 39 | mixed-etiology | 1 |
| 40 | multi-infarctual | 1 |
| 41 | non-dilating | 1 |
| 42 | nonbismuth-containing | 1 |
| 43 | non–antibiotic-appropriate | 1 |
| 44 | photocoagulating | 1 |
| 45 | re-ablating | 1 |
| 46 | relapse/refractory | 1 |
| 47 | renegotiate | 1 |
| 48 | sacro-rectal | 1 |
| 49 | staff-reported | 1 |
| 50 | station.creating | 1 |
| 51 | strepcococcus | 1 |
| 52 | sub-severe | 1 |
| 53 | subreceptor | 1 |
| 54 | t-s. | 1 |
| 55 | tre-at | 1 |
| 56 | tufuga | 1 |
| 57 | under-exaggerates | 1 |
| 58 | ε. | 1 |
| 1 | 'rop | 1 |
| 2 | /or | 20 |
| 3 | 1-5x | 1 |
| 4 | 2,940-nm | 2 |
| 5 | 21,694 | 1 |
| 6 | 3-hydroxy-3methylglutaryl-coenzyme | 1 |
| 7 | 4,6-o-benzylidene | 1 |
| 8 | 4.0-706.1 | 1 |
| 9 | 7-without | 1 |
| 10 | adulthood-onset | 3 |
| 11 | c-p. | 1 |
| 12 | canadienne | 1 |
| 13 | con+insoluble | 1 |
| 14 | con+soluble | 1 |
| 15 | cr-without | 1 |
| 16 | curaderos | 1 |
| 17 | cxcl10-treated | 1 |
| 18 | dregs | 1 |
| 19 | early-by | 1 |
| 20 | europe.in | 1 |
| 21 | exposures.in | 1 |
| 22 | fasting.in | 1 |
| 23 | fviia/fx-induced | 1 |
| 24 | had≥two | 1 |
| 25 | isourolithin | 2 |
| 26 | lys/kg | 1 |
| 27 | metal-on-polymer | 1 |
| 28 | methotrexate+cyclosporin | 1 |
| 29 | methotrexate+cyclosporine | 1 |
| 30 | mixed-etiology | 1 |
| 31 | multi-infarctual | 1 |
| 32 | non-beta-lactamase | 2 |
| 33 | non-dilating | 1 |
| 34 | nonbismuth-containing | 1 |
| 35 | nonlateralizing | 3 |
| 36 | non–antibiotic-appropriate | 1 |
| 37 | pennyroyal | 3 |
| 38 | photocoagulating | 1 |
| 39 | pre/ | 2 |
| 40 | questionnaire-male | 3 |
| 41 | re-ablating | 1 |
| 42 | relapse/refractory | 1 |
| 43 | renegotiate | 1 |
| 44 | sacro-rectal | 1 |
| 45 | staff-reported | 1 |
| 46 | station.creating | 1 |
| 47 | strepcococcus | 1 |
| 48 | sub-severe | 1 |
| 49 | subreceptor | 1 |
| 50 | t-s. | 1 |
| 51 | tj-43-treated | 2 |
| 52 | tre-at | 1 |
| 53 | tufuga | 1 |
| 54 | under-exaggerates | 1 |
| 55 | with-out | 4 |
| 56 | with/without | 244 |
| 57 | without | 54,967 |
| 58 | ε. | 1 |
| 1 | c-p. | 1 |
| 2 | t-s. | 1 |
| 3 | ε. | 1 |
| 4 | pre/ | 2 |
| 5 | 4.0-706.1 | 1 |
| 6 | 21,694 | 1 |
| 7 | tufuga | 1 |
| 8 | fviia/fx-induced | 1 |
| 9 | cxcl10-treated | 1 |
| 10 | tj-43-treated | 2 |
| 11 | staff-reported | 1 |
| 12 | questionnaire-male | 3 |
| 13 | con+soluble | 1 |
| 14 | con+insoluble | 1 |
| 15 | 3-hydroxy-3methylglutaryl-coenzyme | 1 |
| 16 | 4,6-o-benzylidene | 1 |
| 17 | methotrexate+cyclosporine | 1 |
| 18 | canadienne | 1 |
| 19 | sub-severe | 1 |
| 20 | non-beta-lactamase | 2 |
| 21 | non–antibiotic-appropriate | 1 |
| 22 | renegotiate | 1 |
| 23 | lys/kg | 1 |
| 24 | nonbismuth-containing | 1 |
| 25 | station.creating | 1 |
| 26 | re-ablating | 1 |
| 27 | non-dilating | 1 |
| 28 | photocoagulating | 1 |
| 29 | nonlateralizing | 3 |
| 30 | sacro-rectal | 1 |
| 31 | multi-infarctual | 1 |
| 32 | pennyroyal | 3 |
| 33 | 2,940-nm | 2 |
| 34 | europe.in | 1 |
| 35 | fasting.in | 1 |
| 36 | exposures.in | 1 |
| 37 | isourolithin | 2 |
| 38 | methotrexate+cyclosporin | 1 |
| 39 | had≥two | 1 |
| 40 | 'rop | 1 |
| 41 | metal-on-polymer | 1 |
| 42 | /or | 20 |
| 43 | subreceptor | 1 |
| 44 | under-exaggerates | 1 |
| 45 | dregs | 1 |
| 46 | curaderos | 1 |
| 47 | strepcococcus | 1 |
| 48 | tre-at | 1 |
| 49 | adulthood-onset | 3 |
| 50 | with-out | 4 |
| 51 | without | 54,967 |
| 52 | 7-without | 1 |
| 53 | cr-without | 1 |
| 54 | with/without | 244 |
| 55 | 1-5x | 1 |
| 56 | early-by | 1 |
| 57 | mixed-etiology | 1 |
| 58 | relapse/refractory | 1 |